QUOTED. 23 February 2021. Akhil Tripathi.
Signifier Medical hopes to raise $100m in 2021 following US clearance of its first product, a daytime neurostimulation device for snoring and mild obstructive sleep apnea. CEO and co-founder Akhil Tripathi discussed the company’s goals.
“We’re advancing applications across the sleep apnea spectrum and have other products in the pipeline to provide daytime solutions for sleep disorders, even at the severe end of the spectrum.” – Akhil Tripathi, CEO, Signifier Medical
- Find out more: Exec Chat: Signifier Medical Investing In ‘Daytime-Only Treatments’ And Diagnostics For Sleep Apnea
Click here for a free trial of Medtech Insight